Topical methods and compositions for the treatment of eye diseases and conditions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8623852
APP PUB NO 20100286065A1
SERIAL NO

12746196

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a new therapeutic approach for the treatment of eye diseases or conditions that allows for the delivery of corticosteroids to the eye's surface but does not cause any of the usual side effects associated with topical administration of corticosteroids. More specifically, the present invention provides methods of treatment involving the administration of a corticosteroid prodrug, such as dexamethasone palmitate, to the surface of the eye. Also provided are pharmaceutical compositions and kits for carrying out such methods of treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVAGALI PHARMA SATHE MAYAN CITY OF FRANCE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lallemand, Frederic Fresnes, FR 23 81
Lambert, Gregory Chatenay Malabry, FR 39 406
Philips, Betty Antony, FR 19 224
Rabinovich, Laura Kadima, IL 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 7, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00